vs
Ecovyst Inc.（ECVT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Ecovyst Inc.的季度营收约是REPLIGEN CORP的1.0倍（$199.4M vs $197.9M），Ecovyst Inc.同比增速更快（34.0% vs 13.6%），Ecovyst Inc.自由现金流更多（$22.9M vs $17.6M），过去两年Ecovyst Inc.的营收复合增速更高（18.7% vs 14.4%）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ECVT vs RGEN — 直观对比
营收规模更大
ECVT
是对方的1.0倍
$197.9M
营收增速更快
ECVT
高出20.3%
13.6%
自由现金流更多
ECVT
多$5.4M
$17.6M
两年增速更快
ECVT
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 23.4% | 52.5% |
| 营业利润率 | 10.9% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 34.0% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.06 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTRGEN
| Q4 25 | $199.4M | $197.9M | ||
| Q3 25 | $204.9M | $188.8M | ||
| Q2 25 | $176.1M | $182.4M | ||
| Q1 25 | $143.1M | $169.2M | ||
| Q4 24 | $148.9M | $174.1M | ||
| Q3 24 | $153.9M | $154.9M | ||
| Q2 24 | $154.0M | $154.1M | ||
| Q1 24 | $141.6M | $151.3M |
净利润ECVTRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-79.3M | $14.9M | ||
| Q2 25 | $6.0M | $14.9M | ||
| Q1 25 | $-3.6M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $14.3M | $-654.0K | ||
| Q2 24 | $8.3M | $3.3M | ||
| Q1 24 | $1.2M | $2.1M |
毛利率ECVTRGEN
| Q4 25 | 23.4% | 52.5% | ||
| Q3 25 | 25.4% | 53.2% | ||
| Q2 25 | 22.8% | 50.0% | ||
| Q1 25 | 13.3% | 53.6% | ||
| Q4 24 | 28.9% | 26.1% | ||
| Q3 24 | 29.3% | 50.0% | ||
| Q2 24 | 27.3% | 49.8% | ||
| Q1 24 | 23.5% | 49.5% |
营业利润率ECVTRGEN
| Q4 25 | 10.9% | 9.0% | ||
| Q3 25 | 13.8% | 8.9% | ||
| Q2 25 | 9.0% | 7.6% | ||
| Q1 25 | -0.7% | 3.9% | ||
| Q4 24 | 15.1% | -17.7% | ||
| Q3 24 | 17.9% | -5.1% | ||
| Q2 24 | 14.1% | 1.0% | ||
| Q1 24 | 9.5% | 1.3% |
净利率ECVTRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -38.7% | 7.9% | ||
| Q2 25 | 3.4% | 8.2% | ||
| Q1 25 | -2.5% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 9.3% | -0.4% | ||
| Q2 24 | 5.4% | 2.2% | ||
| Q1 24 | 0.9% | 1.4% |
每股收益（稀释后）ECVTRGEN
| Q4 25 | $0.06 | $0.24 | ||
| Q3 25 | $-0.69 | $0.26 | ||
| Q2 25 | $0.05 | $0.26 | ||
| Q1 25 | $-0.03 | $0.10 | ||
| Q4 24 | $-0.26 | $-0.55 | ||
| Q3 24 | $0.12 | $-0.01 | ||
| Q2 24 | $0.07 | $0.06 | ||
| Q1 24 | $0.01 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $767.6M |
| 总债务越低越好 | $392.6M | $542.2M |
| 股东权益账面价值 | $603.4M | $2.1B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.65× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ECVTRGEN
| Q4 25 | $197.2M | $767.6M | ||
| Q3 25 | $82.0M | $748.7M | ||
| Q2 25 | $69.6M | $708.9M | ||
| Q1 25 | $127.5M | $697.2M | ||
| Q4 24 | $131.4M | $757.4M | ||
| Q3 24 | $123.5M | $784.0M | ||
| Q2 24 | $83.3M | $809.1M | ||
| Q1 24 | $103.1M | $780.6M |
总债务ECVTRGEN
| Q4 25 | $392.6M | $542.2M | ||
| Q3 25 | $854.8M | $537.9M | ||
| Q2 25 | $856.6M | — | ||
| Q1 25 | $859.0M | — | ||
| Q4 24 | $860.8M | $525.6M | ||
| Q3 24 | $862.7M | — | ||
| Q2 24 | $862.4M | — | ||
| Q1 24 | $866.2M | — |
股东权益ECVTRGEN
| Q4 25 | $603.4M | $2.1B | ||
| Q3 25 | $607.9M | $2.1B | ||
| Q2 25 | $692.4M | $2.1B | ||
| Q1 25 | $698.7M | $2.0B | ||
| Q4 24 | $700.5M | $2.0B | ||
| Q3 24 | $729.4M | $2.0B | ||
| Q2 24 | $717.3M | $2.0B | ||
| Q1 24 | $711.4M | $2.0B |
总资产ECVTRGEN
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.8B | $2.9B | ||
| Q1 25 | $1.8B | $2.9B | ||
| Q4 24 | $1.8B | $2.8B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $1.8B | $2.9B | ||
| Q1 24 | $1.8B | $2.8B |
负债/权益比ECVTRGEN
| Q4 25 | 0.65× | 0.26× | ||
| Q3 25 | 1.41× | 0.26× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | 1.23× | — | ||
| Q4 24 | 1.23× | 0.27× | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 11.5% | 8.9% |
| 资本支出强度资本支出/营收 | 9.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $69.9M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ECVTRGEN
| Q4 25 | $41.8M | $25.7M | ||
| Q3 25 | $55.3M | $48.1M | ||
| Q2 25 | $33.0M | $28.6M | ||
| Q1 25 | $10.3M | $15.0M | ||
| Q4 24 | $43.5M | $39.2M | ||
| Q3 24 | $59.9M | $49.3M | ||
| Q2 24 | $10.0M | $42.2M | ||
| Q1 24 | $36.5M | $44.7M |
自由现金流ECVTRGEN
| Q4 25 | $22.9M | $17.6M | ||
| Q3 25 | $53.2M | $43.4M | ||
| Q2 25 | $7.8M | $21.5M | ||
| Q1 25 | $-14.0M | $11.4M | ||
| Q4 24 | $30.9M | $33.6M | ||
| Q3 24 | $53.6M | $42.3M | ||
| Q2 24 | $-9.3M | $37.4M | ||
| Q1 24 | $19.1M | $36.4M |
自由现金流率ECVTRGEN
| Q4 25 | 11.5% | 8.9% | ||
| Q3 25 | 26.0% | 23.0% | ||
| Q2 25 | 4.4% | 11.8% | ||
| Q1 25 | -9.8% | 6.8% | ||
| Q4 24 | 20.7% | 19.3% | ||
| Q3 24 | 34.9% | 27.3% | ||
| Q2 24 | -6.1% | 24.3% | ||
| Q1 24 | 13.5% | 24.0% |
资本支出强度ECVTRGEN
| Q4 25 | 9.4% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 14.4% | 3.9% | ||
| Q1 25 | 16.9% | 2.1% | ||
| Q4 24 | 8.5% | 3.2% | ||
| Q3 24 | 4.1% | 4.5% | ||
| Q2 24 | 12.5% | 3.1% | ||
| Q1 24 | 12.3% | 5.5% |
现金转化率ECVTRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 5.52× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.21× | — | ||
| Q2 24 | 1.20× | 12.70× | ||
| Q1 24 | 29.90× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
RGEN
暂无分部数据
